Neonatal Seizures: Electroclinical Patterns and Management

Neonatal seizures are time-sensitive signs of abnormal brain activity during the first weeks of life. They may reflect hypoxic-ischemic injury, stroke, infection, metabolic disturbance, genetic disease, or a structural brain abnormality. Because newborns often show subtle or inconsistent clinical movements, diagnosis depends on combining bedside observation with electroencephalography (EEG).

The subject has long been central to perinatal and neonatal medicine, including the scientific discussions associated with the FAOPS and PREBIC AA meetings in Tokyo. The FAOPS 2020 congress site preserves the broader academic context of a planned international gathering that was canceled in April 2020 because of the COVID-19 pandemic and travel restrictions.

Modern care has shifted from treating every suspicious movement as a seizure to identifying electrographic seizures, determining their cause, and limiting ongoing brain injury. This approach requires rapid stabilization, continuous monitoring when available, targeted investigations, and careful selection of antiseizure medication.

Recognizing Seizure Activity In Newborns

Neonatal seizures can appear as clonic jerking, tonic stiffening, repetitive automatisms, eye deviation, cycling movements, or brief episodes of apnea accompanied by autonomic changes. Focal clonic seizures are often easier to recognize because they involve rhythmic movement in one limb or one side of the face. Generalized tonic events may involve sustained extension or flexion of the trunk and limbs.

Many episodes are more subtle. Lip smacking, tongue movements, bicycling motions, ocular deviation, or sudden changes in heart rate may be seizure-related, but these signs are also produced by nonepileptic neonatal behaviors. Jitteriness, for example, is usually stimulus-sensitive and can often be stopped by holding the affected limb, whereas clonic seizure activity tends to persist independently of restraint.

A lack of visible movement does not exclude a seizure. Some newborns have electrical seizures without a clear clinical correlate, particularly after hypoxic-ischemic encephalopathy or treatment with antiseizure medication. This clinical-electrical separation, known as electroclinical dissociation, is one reason bedside assessment alone is insufficient.

Electroclinical Patterns On EEG

The EEG pattern provides information that observation cannot. A typical electrographic seizure consists of an evolving, repetitive rhythmic discharge with a change in frequency, amplitude, morphology, or field over time. It usually lasts at least several seconds and has a plausible cerebral distribution. Video-EEG allows clinicians to compare the electrical event with the infant’s behavior.

Neonatal seizures may be focal, multifocal, or bilateral. Focal seizures can arise from one region and spread, while multifocal seizures emerge independently from several regions. Some infants show frequent brief seizures that recur over hours, producing a high seizure burden even when individual events are difficult to see.

Background EEG is equally important. A continuous, age-appropriate background is generally more reassuring than a severely suppressed or discontinuous tracing. Burst-suppression patterns, persistent low voltage, or markedly abnormal background activity may indicate significant encephalopathy, although interpretation must account for gestational age, medications, temperature treatment, and the clinical setting.

Amplitude-integrated EEG can support rapid bedside surveillance, but conventional multichannel EEG remains more sensitive for seizure detection. Monitoring should continue long enough to capture delayed or subclinical events, especially in critically ill newborns. A normal short recording does not reliably exclude intermittent neonatal seizures.

Causes That Shape Immediate Management

The first management decision is not which drug to administer; it is identifying and correcting reversible causes. Bedside glucose should be checked promptly, followed by assessment of calcium, magnesium, sodium, and other relevant metabolic markers. Hypoglycemia and hypocalcemia can independently provoke seizures and require immediate correction.

Hypoxic-ischemic encephalopathy is a major cause in term and near-term infants. When eligibility criteria are met, therapeutic hypothermia should begin within the accepted treatment window, with seizure monitoring integrated into neuroprotective care. Perinatal arterial ischemic stroke, cerebral venous thrombosis, intracranial hemorrhage, and malformations of cortical development require neuroimaging, usually beginning with cranial ultrasound when appropriate and advancing to MRI.

Infection must be considered when seizures occur with temperature instability, lethargy, poor feeding, respiratory illness, or other systemic signs. Evaluation may include blood cultures, inflammatory testing, lumbar puncture when safe, and empiric antimicrobial or antiviral therapy. If seizures remain unexplained, clinicians may investigate inborn errors of metabolism and genetic epileptic encephalopathies.

The cause also influences prognosis, treatment duration, and counseling. A single acute symptomatic seizure in an infant with a reversible metabolic abnormality carries a different risk profile from recurrent seizures associated with a brain injury or pathogenic genetic variant. Treatment plans should therefore be individualized rather than based only on the visible event.

A Structured Approach To Acute Treatment

Stabilization follows neonatal priorities: airway, breathing, circulation, temperature, and glucose. Seizure activity should be documented with time, duration, body distribution, associated autonomic changes, and response to intervention. A visible episode lasting several minutes, repeated seizures without recovery, or a rising electrographic seizure burden warrants urgent escalation.

Once a correctable cause is addressed, antiseizure treatment may be required for ongoing seizures. Phenobarbital remains widely used as an initial medication in many protocols, although its effectiveness varies by etiology and it can cause sedation, respiratory depression, and hypotension. Treatment should be guided by EEG whenever possible, because clinical cessation does not prove that electrical seizures have stopped.

If seizures continue, clinicians may consider alternatives such as levetiracetam, phenytoin or fosphenytoin, midazolam, or lidocaine, depending on local expertise, cardiovascular status, suspected cause, and drug availability. Evidence for comparative efficacy in newborns is still developing. Medication choice should balance rapid seizure control against effects on respiration, blood pressure, feeding, and the developing brain.

Care teams should distinguish treatment-resistant seizures from an untreated underlying disorder. Persistent hypoglycemia, infection, electrolyte imbalance, or ongoing cerebral injury can make pharmacological control difficult. Repeated medication doses without reassessing the diagnosis, EEG, and cause may increase toxicity without improving neurological outcomes.

Monitoring, Prognosis, And Family Communication

Continuous EEG is especially valuable for infants with moderate or severe encephalopathy, suspected seizures that lack a clear clinical expression, recurrent events, or seizures after resuscitation. Monitoring often continues after the last observed seizure because electrographic recurrence is common. The duration depends on the infant’s condition, background EEG, treatment response, and institutional protocol.

Prognosis cannot be determined from seizure count alone. Important factors include the underlying diagnosis, gestational age, neurological examination, EEG background, seizure burden, MRI findings, and response to treatment. Follow-up should assess motor development, tone, vision, hearing, feeding, cognition, and later epilepsy risk.

Parents need clear explanations that abnormal movements do not always equal seizures and that an absence of visible movements does not guarantee electrical control. Families may also need practical guidance about monitoring, medication adverse effects, feeding difficulties, safe sleep, and when to seek urgent care. Discussions should be updated as test results become available rather than presenting an early estimate as fixed.

The wider context of perinatal care matters as well. Resources such as perinatal disability care highlight the importance of accessible communication, respectful decision-making, and individualized support for women and families navigating complex pregnancy and newborn care.

Coordinating A Multidisciplinary Care Pathway

Effective seizure management depends on coordination among neonatologists, neurologists, nurses, EEG technologists, radiologists, pharmacists, developmental specialists, and, when needed, infectious disease or metabolic teams. Standardized protocols reduce delays in glucose testing, EEG initiation, medication administration, and escalation of care.

Every suspected event should generate useful clinical data. Video recording, when safe and permitted, can help specialists compare the movement with EEG findings. Medication timing, seizure duration, laboratory results, and treatment response should be documented in a shared record. This information improves handovers and supports later decisions about discontinuing medication.

Decisions about discharge medication are increasingly individualized. Infants whose seizures were acute, resolved, and associated with a normalizing neurological examination may not need prolonged antiseizure therapy. Others require continued treatment and specialist follow-up because of abnormal MRI findings, persistent EEG abnormalities, recurrent seizures, or a diagnosed epilepsy syndrome.

Research and ethical discussion also shape neonatal practice. Questions about long-term medication exposure, neuroprotection, genetic testing, and the use of stored biological material require careful consent and transparent communication. Background reading on cord blood banking illustrates how scientific possibility must be considered alongside evidence, equity, privacy, and family expectations.

Practical Priorities For Safer Care

A consistent bedside process helps teams act quickly without treating every abnormal movement reflexively. The following priorities support accurate diagnosis and safer intervention:

• Stabilize airway, breathing, circulation, temperature, and glucose before focusing exclusively on seizure medication.
• Start urgent EEG monitoring for high-risk infants or events that are subtle, recurrent, prolonged, or difficult to classify clinically.
• Search systematically for hypoxic-ischemic, metabolic, infectious, vascular, structural, genetic, and toxic causes.
• Treat persistent electrographic seizures while reassessing medication effects, seizure burden, and the underlying disease.
• Provide families with plain-language updates, realistic prognostic information, and a clear neurological follow-up plan.

Protocol-based care should still leave room for clinical judgment. Gestational age, comorbidities, local resources, medication availability, and the infant’s response all influence decisions. The most reliable pathway is one that combines rapid action with repeated reassessment rather than relying on a single examination or isolated EEG segment.

The field continues to evolve as better EEG access, advanced imaging, genetic testing, and neuroprotective strategies become available. Clinicians can use the preserved educational material from the FAOPS community as a reminder that neonatal seizure care is an international, multidisciplinary effort grounded in careful observation and scientific exchange.

For clinicians, trainees, and families seeking to strengthen their understanding, review neonatal EEG principles, emergency protocols, and follow-up standards through reputable neonatal and neurology organizations. Early recognition, timely monitoring, and coordinated treatment can reduce avoidable harm while giving each infant the most informed path toward recovery and long-term development.